Insights & Resources

Learn how economic experts assess lost earnings, household services and future medical costs to ensure fair compensation in personal injury cases.

Explore ASC 805’s role in bringing clarity to business combinations — from fair value measurements to goodwill and beyond.

A new executive order pauses FCPA enforcement for 180 days, raising questions about its implications for U.S. companies with international operations.

Simplify your decisions during a divorce with the C.L.E.A.R. process. Learn how to organize, prioritize and plan for a confident financial future.

J.P. Morgan’s Q3 2024 Biopharma Report highlights robust venture investments, shifting licensing trends and a resurgence in IPO activity.

The Q3 2024 Medtech Report from J.P. Morgan spotlights heightened investments, mergers and public offerings, signaling a positive industry outlook.

New York’s business interruption law introduced new stand-alone coverage opportunities, providing businesses options for tailored protection.

Due diligence is a crucial step in any merger and acquisition process. This can be especially challenging for Software-as-a-Service (SaaS) companies.

With an increasing demand for lithium across the energy sector, oilfields may find a common biproduct may hold the key to future growth.

The medical technology, or medtech, industry is poised for a transformative year despite soft IPO activity the first half of 2024. Learn more here.

Discovery target lists can enhance asset recovery efforts in litigation and judgment enforcement by providing a strategic roadmap for enforcement and collections.

By adopting best practices for fraud prevention and fostering a culture of transparency, NFPs can safeguard their resources and continue to make a positive impact.